Reported Consolidated quarterly numbers for Vivimed Labs are:
Net Sales at Rs 25.61 crore in March 2025 down 33.67% from Rs. 38.62 crore in March 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 5.60 crore in March 2025 down 206.42% from Rs. 5.26 crore in March 2024.
EBITDA stands at Rs. 1.75 crore in March 2025 up 111.65% from Rs. 15.02 crore in March 2024.
Vivimed Labs shares closed at 4.95 on July 31, 2023 (NSE)
Story continues below Advertisement
| Vivimed Labs | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 25.61 | 36.51 | 38.62 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 25.61 | 36.51 | 38.62 | | EXPENDITURE | | Consumption of Raw Materials | 7.76 | 14.71 | 33.89 | | Purchase of Traded Goods | -- | -- | -1.41 | | Increase/Decrease in Stocks | 3.69 | 4.97 | -18.60 | | Power & Fuel | -- | -- | -- | | Employees Cost | 8.79 | 7.29 | 6.99 | | Depreciation | 5.50 | 6.62 | 5.83 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 7.85 | 8.47 | 40.38 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -7.96 | -5.56 | -28.48 | | Other Income | 4.22 | 0.07 | 7.63 | | P/L Before Int., Excpt. Items & Tax | -3.75 | -5.49 | -20.85 | | Interest | 1.74 | 0.48 | -33.33 | | P/L Before Exceptional Items & Tax | -5.49 | -5.98 | 12.48 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -5.49 | -5.98 | 12.48 | | Tax | 0.11 | -- | 1.39 | | P/L After Tax from Ordinary Activities | -5.60 | -5.98 | 11.09 | | Prior Year Adjustments | -- | -- | -5.83 | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -5.60 | -5.98 | 5.26 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -5.60 | -5.98 | 5.26 | | Equity Share Capital | 16.58 | 16.58 | 16.58 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.68 | -0.72 | 0.63 | | Diluted EPS | -0.68 | -0.70 | 0.62 | | EPS After Extra Ordinary | | Basic EPS | -0.68 | -0.72 | 0.63 | | Diluted EPS | -0.68 | -0.70 | 0.62 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
